227 related articles for article (PubMed ID: 30889862)
21. Synthesis of sulfonylhydrazone- and acylhydrazone-substituted 8-ethoxy-3-nitro-2H-chromenes as potent antiproliferative and apoptosis inducing agents.
Zhang D; Ma Y; Liu Y; Liu ZP
Arch Pharm (Weinheim); 2014 Aug; 347(8):576-88. PubMed ID: 24866448
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and biological evaluation of novel α-acyloxy carboxamides via Passerini reaction as caspase 3/7 activators.
Salah Ayoup M; Wahby Y; Abdel-Hamid H; Ramadan ES; Teleb M; Abu-Serie MM; Noby A
Eur J Med Chem; 2019 Apr; 168():340-356. PubMed ID: 30826510
[TBL] [Abstract][Full Text] [Related]
23. Development of potential anticancer agents and apoptotic inducers based on 4-aryl-4H chromene scaffold: Design, synthesis, biological evaluation and insight on their proliferation inhibition mechanism.
Elshemy HAH; Zaki MA; Mahmoud AM; Khan SI; Chittiboyina AG; Kamal AM
Bioorg Chem; 2022 Jan; 118():105475. PubMed ID: 34800886
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, antitumor screening and cell cycle analysis of novel benzothieno[3,2-b]pyran derivatives.
Zaher AF; Abuel-Maaty SM; El-Nassan HB; Amer SA; Abdelghany TM
J Enzyme Inhib Med Chem; 2016; 31(sup4):145-153. PubMed ID: 27590401
[TBL] [Abstract][Full Text] [Related]
25. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 3. Structure-activity relationships of fused rings at the 7,8-positions.
Kemnitzer W; Drewe J; Jiang S; Zhang H; Zhao J; Crogan-Grundy C; Xu L; Lamothe S; Gourdeau H; Denis R; Tseng B; Kasibhatla S; Cai SX
J Med Chem; 2007 Jun; 50(12):2858-64. PubMed ID: 17497765
[TBL] [Abstract][Full Text] [Related]
26. Rational design and synthesis of 6-aryl-6H-benzo[c]chromenes as non-steroidal progesterone receptor antagonists for use against cancers.
Qin J; Qu S; Zhu K; Cheng Y; Pan G; Jing W; Liu X; Sun X; Liu L
Bioorg Med Chem; 2021 Feb; 32():116003. PubMed ID: 33461148
[TBL] [Abstract][Full Text] [Related]
27. New synthetic chitosan hybrids bearing some heterocyclic moieties with potential activity as anticancer and apoptosis inducers.
El-Naggar MM; Haneen DSA; Mehany ABM; Khalil MT
Int J Biol Macromol; 2020 May; 150():1323-1330. PubMed ID: 31743719
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of novel chromene derivatives of expected antitumor activity.
Kandeel MM; Kamal AM; Abdelall EK; Elshemy HA
Eur J Med Chem; 2013 Jan; 59():183-93. PubMed ID: 23220647
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and Characterization of Novel 4-aryl-4
Adibi H; Hosseinzadeh L; Amirafshari M; Jalilian F
Anticancer Agents Med Chem; 2023; 23(14):1634-1643. PubMed ID: 37143273
[TBL] [Abstract][Full Text] [Related]
30. A New Family of Benzo[
Abd-El-Aziz AS; Alsaggaf A; Assirey E; Naqvi A; Okasha RM; Afifi TH; Hagar M
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802075
[TBL] [Abstract][Full Text] [Related]
31. Discovery of 4-aryl-4H-chromenes as potent apoptosis inducers using a cell- and caspase-based Anti-cancer Screening Apoptosis Program (ASAP): SAR studies and the identification of novel vascular disrupting agents.
Cai SX; Drewe J; Kemnitzer W
Anticancer Agents Med Chem; 2009 May; 9(4):437-56. PubMed ID: 19442043
[TBL] [Abstract][Full Text] [Related]
32. 5-Chlorobenzofuran-2-carboxamides: From allosteric CB1 modulators to potential apoptotic antitumor agents.
Youssif BGM; Mohamed AM; Osman EEA; Abou-Ghadir OF; Elnaggar DH; Abdelrahman MH; Treamblu L; Gomaa HAM
Eur J Med Chem; 2019 Sep; 177():1-11. PubMed ID: 31128433
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and in-vitro cytotoxicity of poly-functionalized 4-(2-arylthiazol-4-yl)-4H-chromenes.
Mahmoodi M; Aliabadi A; Emami S; Safavi M; Rajabalian S; Mohagheghi MA; Khoshzaban A; Samzadeh-Kermani A; Lamei N; Shafiee A; Foroumadi A
Arch Pharm (Weinheim); 2010 Jul; 343(7):411-6. PubMed ID: 20309872
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of antitumor activity of 9-methoxy-1H-benzo[f]chromene derivatives.
Elgaafary M; Lehner J; Fouda AM; Hamed A; Ulrich J; Simmet T; Syrovets T; El-Agrody AM
Bioorg Chem; 2021 Nov; 116():105402. PubMed ID: 34670333
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, Fluorescence Properties, and Antiproliferative Potential of Several 3-Oxo-3H-benzo[f]chromene-2-carboxylic Acid Derivatives.
Fu XB; Wang XF; Chen JN; Wu DW; Li T; Shen XC; Qin JK
Molecules; 2015 Oct; 20(10):18565-84. PubMed ID: 26473819
[TBL] [Abstract][Full Text] [Related]
36. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 2. Structure-activity relationships of the 7- and 5-, 6-, 8-positions.
Kemnitzer W; Kasibhatla S; Jiang S; Zhang H; Zhao J; Jia S; Xu L; Crogan-Grundy C; Denis R; Barriault N; Vaillancourt L; Charron S; Dodd J; Attardo G; Labrecque D; Lamothe S; Gourdeau H; Tseng B; Drewe J; Cai SX
Bioorg Med Chem Lett; 2005 Nov; 15(21):4745-51. PubMed ID: 16143530
[TBL] [Abstract][Full Text] [Related]
37. Novel pyrazolo[3,4-d]pyrimidines: design, synthesis, anticancer activity, dual EGFR/ErbB2 receptor tyrosine kinases inhibitory activity, effects on cell cycle profile and caspase-3-mediated apoptosis.
Maher M; Kassab AE; Zaher AF; Mahmoud Z
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):532-546. PubMed ID: 30688116
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and anticancer activity of heteroaromatic linked 4β-amido podophyllotoxins as apoptotic inducing agents.
Kamal A; Tamboli JR; Vishnuvardhan MV; Adil SF; Nayak VL; Ramakrishna S
Bioorg Med Chem Lett; 2013 Jan; 23(1):273-80. PubMed ID: 23182091
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, molecular modelling, and biological evaluation of novel substituted pyrimidine derivatives as potential anticancer agents for hepatocellular carcinoma.
Ahmed NM; Youns M; Soltan MK; Said AM
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1110-1120. PubMed ID: 31117890
[TBL] [Abstract][Full Text] [Related]
40. Development of 1,3,4-oxadiazole thione based novel anticancer agents: Design, synthesis and in-vitro studies.
Yadav N; Kumar P; Chhikara A; Chopra M
Biomed Pharmacother; 2017 Nov; 95():721-730. PubMed ID: 28888209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
